» Authors » Roberto Da Cas

Roberto Da Cas

Explore the profile of Roberto Da Cas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 544
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Da Cas R, Spila Alegiani S, Mayer F, Cutillo M, Morciano C, Annunziata A, et al.
Recenti Prog Med . 2024 Dec; 115(12):614-615. PMID: 39688049
Aim of the study was to assess the use of pharmacological therapies provided in Nursing Homes and Protected Residences of the Umbria Region, with reference to central nervous system medications....
2.
Ippoliti I, Da Cas R, Marano G, Annunziata A, Salvi E, Ruggeri P, et al.
Recenti Prog Med . 2024 Nov; 115(11):566-567. PMID: 39550666
Objectives: To assess the safety profile of dietary supplements with a focus on those purchased online or reported via the internet. Results: Among the 2,367 reports of Adverse Reactions (ARs)...
3.
Valerio A, Rotondi D, Da Cas R, Pricci F, Traversa G
Recenti Prog Med . 2024 Nov; 115(11):511-516. PMID: 39550646
Introduction: The availability of epidemiological data relating to the therapy with somatropin (recombinant Growth Hormone, rGH) is scarce and mostly limited to specific clinical conditions. In Italy, the National Register...
4.
Marano G, Arcieri R, Rocchi R, Annunziata A, Cutillo M, Bucaneve G, et al.
Ann Ist Super Sanita . 2024 Sep; 60(3):208-215. PMID: 39269002
Introduction: Chronic diseases, such as hemophilia, can evoke psychological sequelae and be associated with a higher risk of mental health disorders. The utilization of antidepressant and antipsychotic drugs in subjects...
5.
Morciano C, Massari M, Cutillo M, Belleudi V, Trifiro G, Mores N, et al.
Drug Saf . 2024 Jul; 47(11):1157-1169. PMID: 39068268
Background And Objective: Cases of appendicitis were identified in the pivotal randomized clinical trial on BNT162b2 mRNA vaccine and reported from coronavirus disease 2019 (COVID-19) vaccine pharmacovigilance systems. Three cohort...
6.
Gagliotti C, Cangini A, Da Cas R, Ippoliti I, Trotta F, Fortinguerra F
JAC Antimicrob Resist . 2024 Jul; 6(4):dlae110. PMID: 39045219
Background: Monitoring consumption through quality indicators and providing feedback is an important activity within programmes for improving antibiotic prescription. This study aims to describe the use of antibiotics for systemic...
7.
De Masi S, Da Cas R, Ippolito F, Baglio G, Zoccali C, Chiarotti F, et al.
J Nephrol . 2024 Jul; 37(7):1871-1880. PMID: 38995613
Background: The aim of this study was to evaluate the impact on the national health system of COVID-19 infection in vaccinated patients undergoing haemodialysis. Methods: From the cohort of vaccinated...
8.
Marano G, Capannini E, Annunziata A, Trotta F, Da Cas R, Mucci L
Epidemiol Prev . 2024 Jul; 48(3):233-238. PMID: 38995136
Objectives: to assess the variability in expenditure compared to 2022 assuming different rates of shifting of therapy days from current active ingredients used for the treatment of haemophilia B to...
9.
Mateo-Urdiales A, Fabiani M, Mayer F, Sacco C, Belleudi V, Da Cas R, et al.
BMC Public Health . 2024 Jun; 24(1):1569. PMID: 38862939
Background: As of 2024, vaccination remains the main mitigation measure against COVID-19, but there are contradictory results on whether people living with HIV (PLWH) are less protected by vaccines than...
10.
Morciano C, Spila Alegiani S, Ippolito F, Belleudi V, Trifiro G, Zanoni G, et al.
PLoS One . 2024 Jan; 19(1):e0290879. PMID: 38241309
Background: Recently published studies have reported association of COVID-19 vaccine ChAdOx1-S (Vaxzevria) with Guillain Barré Syndrome (GBS). Less is known about the safety of other COVID-19 vaccines with respect to...